2004•Unpublished venueRequires access

Levofloxacin in Treatment of Respiratory Tract Infection

Zhang Chuan-jun

Abstract

OBJECTIVE To evaluate the effect of levofloxacin (Cravit) in the treatment of respiratory tract (infections. )METHODS Eighty patients with respiratory tract infections were divided into two groups in random. The therapy group was injected with levofloxacin 0.3 g bid; the control group was injected with cefoperazone (2 g) bid. Both courses of treatment were 7-14 days. RESULTS The total efficacy rates in therapy and control groups were 87.5% and 75.0%, respectively. The clearance rates of bacteria were 86.21% and 75.00%, respectively. The side effects were all scarce and light in both groups. CONCLUSIONS The effect of levofloxacin is exact and levofloxacin can be used as the first choice drug in the treatment of respiratory tract infections.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Levofloxacin, Cefoperazone, Respiratory tract, Medicine, Respiratory tract infections, Respiratory system, Internal medicine, Drug